Status | Study |
Not yet recruiting |
Study Name: Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure Condition: Liver Failure, Acute Date: 2017-03-14 Interventions: Procedure: hiHep Bioartificial Liver Support System |
Recruiting |
Study Name: 13C-Methacetin Breath Test for the Prediction of Outcome in ALF Condition: Acute Liver Failure Date: 2016-05-06 Interventions: Drug: 13C-methacetin The test substrate in this study, |
Recruiting |
Study Name: High-Volume Plasma Exchange Versus Fractional Plasma Separation and Adsorption (Prometheus) in Patients With Acute Liver Failure Condition: Acute Liver Failure Date: 2016-02-29 Interventions: Biological: High Volume Plasma Exchange Dr |
Recruiting |
Study Name: High Volume Plasma Exchange in Children With Acute Liver Failure Condition: Acute Liver Failure Date: 2016-02-17 Interventions: Biological: High Volume Plasma Exchange Dr |
Recruiting |
Study Name: Steroids in Fulminant Hepatic Failure in the Pediatric Age Group Condition: Fulminant Hepatic Failure Date: 2015-02-14 Interventions: Drug: prednisolone Oral admini |
Recruiting |
Study Name: Comparison of Two Liver Dialysis Systems : MARS Versus SPAD in Severe Liver Failure Condition: Liver Failure, Acute Chronic Hepatic Failure Date: 2014-11-14 Interventions: Device: MARS albumin dialysis system Devic |
Completed |
Study Name: Neuromonitoring of Hepatic Encephalopathy Condition: Liver Failure, Acute Hepatic Encephalopathy Date: 2013-06-06 Interventions: Device: Molecular Adsorbent Recirculating System (MARS) MARS is an extracorporeal albumin dialysis devic |
Terminated |
Study Name: Safety and Efficacy of ELAD to Treat Acute Liver Failure (ALF) Condition: Acute Liver Failure Fulminant Hepatic Fai Date: 2013-06-05 Interventions: Biological: ELAD Continuous treatment with the ELAD System for a minimum of 3 days to a maximum of 10 da |
Completed |
Study Name: Emergency Use of OCR-002 in Acute Liver Failure Condition: Acute Liver Failure Date: 2012-06-25 Interventions: Drug: OCR-002 daily dose: 10g infused over 24 hour O |
Recruiting |
Study Name: Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure Condition: Acute Liver Failure Acute Liver Injury Date: 2012-02-24 Interventions: Drug: Ornithine phenylacetate Up to 36 patients will be en |